Incidence of pseudoaneurysm after diagnostic and therapeutic angiography

Use of a collagen plug versus manual compression for sealing arterial puncture site after cardiac catheterization

The aim of the study was to investigate (1) the safety and efficacy of the application of a collagen plug (Vasoseal) at arterial puncture sites, (2) the hemostasis time, and (3) the comfort for the patient of a collagen plug (Vasoseal) when compared with manual compression. Sixty-two patients were randomized either for application of a collagen plug (Vasoseal, group A, n = 33) or manual compression (group B, n = 29) after cardiac catheterization. All patients were evaluated for subjective pain score ranging from 1 to 5 (1 = no pain up to 5 = very strong pain). In addition the authors measured the time until hemostasis could be achieved. The patients were evaluated by duplex sonography for complications at days 1 and 7 after the procedure. The pain score demonstrated a significantly lower score in group A when compared with group B (P = 0.01). The mean time for hemostasis was significantly lower in group A (mean 9.6 minutes) when compared with group B (mean 23.6 minutes) (P = 0.0001). Regarding the complication rate there was no significant difference between the groups (group A vs group B, P = 0.82). The authors conclude that the application of a collagen plug at the arterial puncture site is a safe and time-saving method. In addition it is less painful and therefore better tolerated than manual compression.

Color flow mapping

Color flow mapping systems have become widely used in the short time since their development. These systems overlay a pseudo-color velocity map upon the gray-scale two-dimensional image. Between 4 and 16 pulses are directed to each line-of-sight, and this requirement reduces the frame rate in comparison with the gray-scale image. Other limitations of color flow mapping include its ability to estimate only the velocity toward or away from the transducer and an increase in the variance in comparison with spectral Doppler. Potential artifacts include aliased velocities and the detection of flow in hypoechoic or hyperechoic nonvascular structures. Clinical applications include cardiology, studies of the abdominal and peripheral vasculature, evaluation of organ perfusion and the differentiation of tumors. Most current systems use narrowband estimators that examine a fixed sample volume and detect a change in phase between two pulses. Wideband estimators that can track red blood cells in two or three dimensions are under evaluation. Narrowband estimators, including the autocorrelator, the short Fourier transform and second order autoregressive filters, are compared with wideband estimators including cross-correlation, sum-absolute-difference and the wideband maximum likelihood estimator. Because the intensity of blood echoes is far smaller than echoes from surrounding tissue, high pass filters have been developed that can reject the larger signal from tissue using the return from a small number of pulses. Other areas of research include strategies for flow estimation with contrast agents, three-dimensional color flow mapping and power Doppler flow mapping.

Unusual pseudoaneurysms after catheterization: successful treatment by ultrasound-guided compression

Postcatheterization pseudoaneurysms occur mostly in the femoral artery. Two patients (both women, aged 67 and 59 years) undergoing percutaneous transluminal angioplasty (PTA) at our institution presented pseudoaneurysms in unusual locations, one in the brachial and one in the popliteal artery. Because of good experiences with ultrasound-guided compression repair (UGCR) in the femoral artery, we also successfully performed this noninvasive treatment on the two patients. Follow-up at 28 and 12 months, respectively, after the procedure, showed no instances of recurrence. As with the excellent results of UGCR in the femoral artery, we believe that this new modality is also the treatment of choice in iatrogenic pseudoaneurysms of the arm and popliteal arteries.

Ultrasound-guided compression repair for treatment of femoral artery pseudoaneurysm: acute and follow-up results

Femoral artery pseudoaneurysm is a significant problem in patients undergoing arterial diagnostic or therapeutic catheterization. The aim of this investigation was to report the incidence of pseudoaneurysm after arterial catheterization and the success rate of ultra-sound-guided compression repair. During a 3-year period (11/91-11/94) 9,051 patients underwent 7,312 cardiac catheterizations and 1,739 peripheral percutaneous transluminal coronary angioplasty procedures. Patients suspect of pseudoaneurysm were referred for a color Doppler ultrasound examination. All patients with pseudoaneurysm were considered for ultrasound-guided compression repair. Pseudoaneurysm occurred more frequently after interventional procedures with new devices (valvuloplasty 2.3%, stent 3.2%) than after conventional catheterization diagnostic cardiac catheterization 0.2%, electrophysiology 1.3%, percutaneous transluminal coronary angioplasty 0.2%). The incidence of pseudoaneurysm after peripheral percutaneous coronary transluminal angioplasty, including intra-arterial lysis and stent, was 1%. Ultrasound-guided compression repair was successfully performed in 37 of 41 cases with pseudoaneurysm (90%). Ultrasound-guided compression repair was successfully performed in 30 of 31 patients (97%) without anticoagulation and in 7 of 10 patients (70%) receiving anticoagulants (P < 0.05). There was no correlation between mean diameter of the pseudoaneurysm, age of the lesion, or antiplatelet therapy. Color Doppler ultrasound re-examination at up to 3 months indicated successful treatment in all patients. The use of complex interventional catheterization procedures leads to an increased frequency of pseudoaneurysms compared with conventional angiography and percutaneous transluminal coronary angioplasty. Ultrasound-guided compression repair is a non-invasive, efficient, safe and cost-effective therapy for post-catheterization pseudoaneurysm.

Multicenter trial of the wallstent in the iliac and femoral arteries

PURPOSE

To report the results of the FDA phase II, multicenter trial of the Wallstent in the iliac and femoral arteries.

PATIENTS AND METHODS

Two hundred twenty-five patients entered the trial. Stents were placed in the iliac system in 140 patients and in the femoral system in 90 (five patients required both iliac and femoral stents). Clinical patency was measured over 2 years by means of life-table analysis with use of clinical and hemodynamic data and the Rutherford scale. Angiographic patency was measured at 6 months.

RESULTS

In the iliac system the primary clinical patency was 81% at 1 year and was 71% at 2 years. The secondary clinical patency was 91% and 86%, respectively. The 6-month angiographic patency was 93%. In the femoral system the primary clinical patency was 61% at 1 year and 49% at 2 years. The secondary patency was 84% and 72%, respectively. The 6-month angiographic patency was 80%.

CONCLUSIONS

The results are similar to those with the Palmaz stent in the iliac system and with angioplasty alone in the iliac and femoral systems.